WASHINGTON — After months of pledging he would get pharmaceutical companies to lower their prices, President Trump can now say that he pressed the CEO of a major drug maker, Pfizer (PFE), to back down on a series of price hikes.

Pfizer, in turn, has earned glowing praise from Trump and his administration and will likely not suffer much, if at all, financially.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I guess in his world, and mind, a delayed increase in prices amounts to a huge drop in the cost of drugs. So, promise kept!
    There is also a chance he is a HUGE fan of the godfather and goodfellas movies, so he made them an offer they couldn’t refuse and it would be a shame something would happen to Pfizer CEO’s family. Capisc?

  • It looks like people are accustomed to the Alternative Facts. This will be spun by the media to make it appear he cured cancer.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy